Skip to content

Understanding the impact upon physical activity of the ?Devon Active Villages? intervention

The Devon Active Villages Evaluation trial: A stepped wedge cluster randomised trial of a community-level physical activity intervention in rural Southwest England

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN37321160
Enrollment
6400
Registered
2012-05-10
Start date
2011-03-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Physical activity Not Applicable

Interventions

During the DAVE study, the community-level physical activity intervention will be rolled out sequentially to 128 rural villages (clusters) over four time periods. The evaluation will consist of data

Sponsors

University of Exeter (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Male and female, and must be aged 18 years or over, there is no upper age limit. 2. The participants in the trial can be patients, health volunteers, doctors, health professionals, there are no excluded professions 3. Residents of one of the 128 intervention villages

Exclusion criteria

Exclusion criteria: 1. Aged 17 or younger 2. The participants cannot live in a location that is not within one of the 128 intervention villages

Design outcomes

Primary

MeasureTime frame
Community levels of physical activity, measured using the International Physical Activity Questionnaire (IPAQ) short form at baseline, and after each of the four intervention periods

Secondary

MeasureTime frame
1. Physical activity intentions 2. Habits and perceived social support for physical activity, measured using questionnaire items based on survey questions from an Australian cohort survey study 3. Awareness and use of local physical activity facilities, measured using questionnaire items based on survey questions found to have acceptable levels of test-retest reliability. Measured at baseline, and after each of the four intervention periods

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 25, 2026